Contineum Therapeutics, Inc. (CTNM) stock
CTNMNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 8/30
$9.55−0.12 (-1.24%)
Close on Nov 17, 2026Market cap $359.28MP/E –Yield –
Contineum Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Contineum Therapeutics's enterprise value was $123.71M on Nov 11, 2026, against $110.24M a year earlier. Over the last 3 years it ranged from -$125.26M to $306.71M, with a median of $77.54M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $123.71M | +3.3% |
| 2025 | Dec 31, 2025 | $119.76M | – |
| 2024 | Dec 31, 2024 | -$13.57M | – |
See a number that looks wrong?